Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Revision History For: Endorex (DOR)

No earlier versions found for this Subject.

Return to Endorex (DOR)

Paramount/Aries, the same group that has been very patiently gobbling up all the Genta (GNTA) stock it can without moving the stock price too much, is doing the same thing with Endorex (DOR), witness the following article from today's Dow Jones Newswire:

Endorex Corp.
Dow Jones Newswires -- May 5, 1999
Paramount Grp/Endorex Corp. -2: Holds 4.1M Common Shares

WASHINGTON (Dow Jones)--A group including Paramount Capital Asset Management Inc. raised its stake in Endorex Corp. (DOR), formerly ImmunoTherapeutics Inc.

In a filing Wednesday with the Securities and Exchange Commission, the group said it currently holds 4.1 million common shares of the Lake Forest, Ill., company.

Check out the purchasing pattern at biz.yahoo.com

In the case of Genta, this buying pattern by the smart money has been a great predicter of future stock price increases. Will history repeat itself with Endorex?

Marc